Literature DB >> 23791407

Bilateral lateral rectus muscle recession with medial rectus pulley fixation for divergence excess intermittent exotropia with high AC/A ratio.

Hee Young Choi1, Jae Ho Jung.   

Abstract

PURPOSE: To evaluate the efficacy of bilateral rectus muscle recession with medial rectus pulley posterior fixation for patients with intermittent exotropia with high AC/A ratio.
METHODS: This study included consecutive patients with exodeviation ≥10(Δ) greater at distance than at near fixation and with a high AC/A ratio who underwent bilateral lateral rectus muscle recession to eliminate the exotropia at distance and pulley posterior suturing on both medial rectus muscles to prevent consecutive esotropia at near fixation. A successful outcome was defined as near or distance angle of exodeviation ≤8(Δ) and a ≤10(Δ) difference between the two.
RESULTS: A total of 7 patients were enrolled. Of these, 5 (71%) achieved successful results. One patient required bifocal correction for postoperative esodeviation at near fixation.
CONCLUSIONS: In this case series, most patients with intermittent exotropia and a high AC/A ratio were successfully treated with bilateral lateral rectus muscle recession combined with medial rectus pulley posterior fixation.
Copyright © 2013 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23791407     DOI: 10.1016/j.jaapos.2013.02.004

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  2 in total

1.  The biomechanical significance of pulley on binocular vision.

Authors:  Hongmei Guo; Zhipeng Gao; Weiyi Chen
Journal:  Biomed Eng Online       Date:  2016-12-28       Impact factor: 2.819

2.  High Accommodative Convergence/Accommodation Ratio Consecutive Esotropia Following Surgery for Intermittent Exotropia: Clinical Feature, Diagnosis, and Treatment.

Authors:  Byung Joo Lee; Hyun Taek Lim
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.